与输血相关的急性肺损伤的潜在病理生理学的关键特征
1Sanquin Research, Department of Experimental Immunohematology, Amsterdam and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Expert review of hematology
|November 29, 2024
概括
与输血相关的急性肺损伤 (TRALI) 是输血导致死亡的主要原因. 研究重点强调补充补充补充.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 关键护理医学 关键护理医学
背景情况:
- 与输血相关的急性肺损伤 (TRALI) 是与输血相关的死亡的一个重要原因,特别是在重症监护病房.
- 特拉利经常被忽视和报告不足,缺乏特定的诊断生物标志物和有效的临床治疗方法.
研究的目的:
- 审查TRALI的关键病理生理特征.
- 要突出最近关于补充,受体免疫细胞 (中性粒细胞,巨细胞) 和肺内皮在TRALI病变发生过程中的作用的发现.
主要方法:
- 关于TRALI病理生理学的当前文献的综述.
- 对补充激活与Fcγ受体 (FcγRs) 的作用的分析.
- 检查免疫细胞和内皮细胞对TRALI的贡献.
主要成果:
- 补充激活是TRALI的关键驱动因素,比Fcγ受体更重要.
- 受体中性粒细胞,巨细胞和肺内皮在TRALI发育中发挥着重要作用.
- 潜在的治疗策略包括IL-10的管理,补充抑制和骨质素 (OPN) 阻塞.
结论:
- 进一步研究TRALI的免疫细胞病理生理学是必不可少的,考虑到临床异质性和输血触发因素.
- 需要鼓励积极报告TRALI病例.
- 新的生物标志物和疗法,如IL-10,补充抑制和OPN阻塞,需要通过多中心临床试验进一步调查,以减少TRALI相关的死亡率.
相关概念视频
01:21Acute Respiratory Failure-II
174
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
174
01:21Acute Respiratory Failure-I
173
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
173
01:29Pneumonia II: Pathophysiology
216
The pathophysiology of pneumonia involves the following steps:
216
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:29Acute Respiratory Failure-V
123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123
01:30Acute Respiratory Failure-III
159
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
159